The latest report by IMARC Group, titled "Cell Isolation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", offers a comprehensive analysis of the industry, which comprises insights on the global cell isolation market trends. The global cell isolation market size reached US$ 11.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 28.5 Billion by 2028, exhibiting a growth rate (CAGR) of 15.7% during 2023-2028.
Cell isolation, also known as cell separation, identifies, isolates and separates targeted cells from a heterogeneous mixture of a cell population. This process helps minimize experimental complexity, reduce the interference from other cell types, and diagnose diseases, cellular research and therapies. In recent years, cell separation has gained prominence as it plays a vital role in therapeutic protein production, in-vitro diagnostics and biologics designing.
Request for a sample copy of this report: https://www.imarcgroup.com/cell-isolation-market/requestsample
Cell Isolation Market Trends and Drivers:
The global cell isolation market is primarily driven by the expanding medical and pharmaceutical industry. Due to this, pharmaceutical manufacturers are using cell isolation technologies to develop drugs with improved efficacies. In addition, they are utilized to develop novel cell therapies and cell-based treatments for various chronic medical ailments. Besides this, with the onset of coronavirus disease (COVID-19), there has been rapid development of novel vaccines, therapies, and testing kits. This has escalated the demand for cell isolation tools for diagnostics and research activities. Moreover, increasing investments in research and development (R&D) by biotechnology and biopharmaceutical companies to manufacture advanced biologics, such as monoclonal antibodies and vaccines, provide a positive outlook to the market in the near future.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Technique:
Centrifugation
Surface Marker
Filtration
Breakup by Cell Type:
Human Cells
Animal Cells
Breakup by Product:
Consumables
Reagents, Kits, Media and Sera
Beads
Disposables
Instruments
Centrifuges
Flow Cytometers
Filtration Systems
Magnetic-activated Cell Separator Systems
Breakup by Application:
Biomolecule Isolation
Therapeutics
Stem Cell Research
Cancer Research
Tissue Regeneration
In-Vitro Diagnostics
Breakup by End Use:
Biotechnology and Biopharmaceutical Companies
Hospitals and Diagnostic Laboratories
Research Laboratories and Institutes
Others
Market Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Competitive Landscape with Key Player:
Alfa Laval AB
Becton Dickinson and Company
Beckman Coulter Inc. (Danaher Corporation)
Bio-Rad Laboratories Inc.
General Electric Company
Merck KGaA
Miltenyi Biotec B.V. & Co. KG
pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG
Roche Holding AG
STEMCELL Technologies Inc.
Terumo Corporation
Thermo Fisher Scientific Inc.
Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=report&id=3942&flag=F
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal